Literature DB >> 21146188

Exercise capacity in pediatric patients with inflammatory bowel disease.

Hilde E Ploeger1, Tim Takken, Boguslaw Wilk, Robert M Issenman, Ryan Sears, Soni Suri, Brian W Timmons.   

Abstract

OBJECTIVE: To examine exercise capacity in youth with Crohn's disease (CD) and ulcerative colitis (UC). STUDY
DESIGN: Eleven males and eight females with CD and six males and four females with UC participated. Patients performed standard exercise tests to assess peak power (PP) and mean power (MP) and peak aerobic mechanical power (W(peak)) and peak oxygen uptake (VO(2peak)). Fitness variables were compared with reference data and also correlated with relevant clinical outcomes.
RESULTS: Pediatric patients with inflammatory bowel disease had lower PP (∼90% of predicted), MP (∼88% of predicted), W(peak) (∼91% of predicted), and VO(2peak) (∼75% of predicted) compared with reference values. When patients with CD or UC were compared separately to reference values, W(peak) was significantly lower only in the CD group. No statistically significant correlations were found between any exercise variables and disease duration (r = 0.01 to 0.14, P = .47 to .95) or disease activity (r = -0.19 to -0.31, P = .11 to .38), measured by pediatric CD activity index or pediatric ulcerative colitis activity index. After controlling for chronological age, recent hemoglobin levels were significantly correlated with PP (r = 0.45, P = .049), MP (r = 0.63, P = .003), VO(2peak) (r = 0.62, P = .004), and W(peak) (r = 0.70, P = .001).
CONCLUSIONS: Pediatric patients with inflammatory bowel disease exhibit impaired aerobic and anaerobic exercise capacity compared with reference values.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21146188     DOI: 10.1016/j.jpeds.2010.10.020

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission.

Authors:  Patricia D Jones; Michael D Kappelman; Christopher F Martin; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

2.  Conceptual Model of Lean Body Mass in Pediatric Inflammatory Bowel Disease.

Authors:  Margaux J Barnes; Mary K Lynch; Molly D Lisenby; Traci Jester; Jeanine Maclin; Taylor Knight; Gordon Fisher; Barbara Gower
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-03       Impact factor: 2.839

3.  Functional recovery following critical illness in children: the "wee-cover" pilot study.

Authors:  Karen Choong; Samah Al-Harbi; Katie Siu; Katie Wong; Ji Cheng; Burke Baird; David Pogorzelski; Brian Timmons; Jan-Willem Gorter; Lehana Thabane; Mary Khetani
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

4.  Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing.

Authors:  J M Otto; A F O'Doherty; P J Hennis; K Mitchell; J S Pate; J A Cooper; M P W Grocott; H E Montgomery
Journal:  Int J Colorectal Dis       Date:  2012-07-29       Impact factor: 2.571

Review 5.  Exercise in patients with inflammatory bowel diseases: current perspectives.

Authors:  Michael Engels; Raymond K Cross; Millie D Long
Journal:  Clin Exp Gastroenterol       Date:  2017-12-22

6.  Physical activity and quality of life of patients with inflammatory bowel disease.

Authors:  Bun Kim; Jisuk Chae; Eun Hye Kim; Hyuk In Yang; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Justin Y Jeon; Soo Jung Park
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

7.  Chemokine (C-C motif) Ligand 2 is a potential biomarker of inflammation & physical fitness in obese children: a cross-sectional study.

Authors:  M Constantine Samaan; Joyce Obeid; Thanh Nguyen; Lehana Thabane; Brian W Timmons
Journal:  BMC Pediatr       Date:  2013-04-04       Impact factor: 2.125

8.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomine A van Pelt; Tim Takken; Marco van Brussel; Mirjam de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-20       Impact factor: 3.054

9.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomien A van Pelt; Tim Takken; Marco van Brussel; Inge de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-27       Impact factor: 3.054

10.  Impact of pediatric inflammatory bowel disease diagnosis on exercise and sports participation: Patient and parent perspectives.

Authors:  Renée M Marchioni Beery; Enju Li; Laurie N Fishman
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.